Neuroendocrine activity of the melanocyte

Experimental Dermatology

Volumn 18, Issue 9, 2009, Pages 760-763

  Slominski, Andrzej ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Homeostasis; Hormones; Melanocytes; Neurotransmitters; Regulatory network; Sensory functions; Stress

Indexed keywords

BETA ENDORPHIN; CALCIUM ION; CATECHOLAMINE; CORTICOSTEROID; CORTICOSTERONE; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; CORTICOTROPIN RELEASING FACTOR RECEPTOR 2; HYDROCORTISONE; INOSITOL TRISPHOSPHATE; INTERMEDIN; LEVODOPA; MELATONIN; N ACETYLSEROTONIN; NEUROPEPTIDE; NEUROTRANSMITTER; PROOPIOMELANOCORTIN; SEROTONIN; UROCORTIN;

ARTICLE; CATECHOLAMINERGIC SYSTEM; CELL PROLIFERATION; HOMEOSTASIS; HORMONE SYNTHESIS; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MELANOCYTE; MELANOGENESIS; NEUROBIOLOGY; NEUROENDOCRINE SYSTEM; NEUROTRANSMITTER RELEASE; PHYSIOLOGICAL STRESS; SENSORY NERVE CELL; SEROTONINERGIC SYSTEM; SIGNAL TRANSDUCTION; ULTRAVIOLET RADIATION;

EPIDERMIS; HOMEOSTASIS; MELANINS; MELANOCYTES; NEUROENDOCRINE CELLS;

EID: 69149092876     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/j.1600-0625.2009.00892.x     Document Type: Article

References (67)

1. Slominski A, Paus R, Schanderdorf D. Melanocytes as sensory and regulatory cells in the epidermis. J Theor Biol 1993: 164: 103-120.
2. Slominski A, Pawelek J. Animals under the sun: Effects of ultraviolet radiation on mammalian skin. Clin Dermatol 1998: 16: 503-515.
3. Pawelek J M, Chakraborty A K, Osber M P et al. Molecular cascades in UV-induced melanogenesis: A central role for melanotropins? Pigment Cell Res 1992: 5: 348-356.
4. Fitzpatrick T B, Breathnach A S. Das epidermale melanin-einheit-system. Dermatol Wochenschr 1963: 147: 481-489.
5. Nordlund J J. The melanocyte and the epidermal melanin unit: An expanded concept. Dermatol Clin 2007: 25: 271-281. vii.
6. Bolognia J, Murray M, Pawelek J. UVB-induced melanogenesis may be mediated through the MSH-receptor system. J Invest Dermatol 1989: 92: 651-656.
7. Slominski A, Paus R. Are L-tyrosine and L-dopa hormone-like bioregulators? J Theor Biol 1990: 143: 123-138.
8. Slominski A, Paus R. Melanogenesis is coupled to murine anagen: Toward new concepts for the role of melanocytes and the regulation of melanogenesis in hair growth. J Invest Dermatol 1993: 101: 90S-97S.
9. Slominski A, Paus R, Wortsman J. On the potential role of proopiomelanocortin in skin physiology and pathology. Mol Cell Endocrinol 1993: 93: C1-C6.
10. Nordlund J J, Boissy R E, Hearing V J, King R A, Oetting W S, Ortonne J-P. The Pigmentary System: Physiology and Pathophysiology. Malden: Blackwell Publishing, 2006.
11. Slominski A, Tobin D J, Shibahara S, Wortsman J. Melanin pigmentation in mammalian skin and its hormonal regulation. Physiol Rev 2004: 84: 1155-1228.
12. Wood J M, Jimbow K, Boissy R E et al. What's the use of generating melanin? Exp Dermatol 1999: 8: 153-164.
13. 2-induced DNA strand breaks through its ability to bind Ca2+. Exp Cell Res 2004: 294: 60-67.
14. Slominski A, Wortsman J. Neuroendocrinology of the skin. Endocrine Rev 2000: 21: 457-487.
15. Slominski A, Goodman-Snitkoff G G. Dopa inhibits induced proliferative activity of murine and human lymphocytes. Anticancer Res 1992: 12: 753-756.
16. Slominski A, Paus R, Mihm M C. Inhibition of melanogenesis as an adjuvant strategy in the treatment of melanotic melanomas: Selective review and hypothesis. Anticancer Res 1998: 18: 3709-3715.
17. Slominski A, Friedrich T. L-dopa inhibits in vitro phosphorylation of melanoma glycoproteins. Pigment Cell Res 1992: 5: 396-399.
18. Slominski A, Moellman G, Kuklinska E, Bomirski A, Pawelek J. Positive regulation of melanin pigmentation by two key substrates of the melanogenic pathway: L-tyrosine and L-dopa. J Cell Sci 1988: 89: 287-296.
19. Slominski A, Moellmann G, Kuklinska E. L-tyrosine, L-dopa and tyrosinase as positive regulators of the subcellular apparatus of melanogenesis in Bomirski Ab amelanotic melanoma. Pigment Cell Res 1989: 2: 109-116.
20. Slominski A, Jastreboff P, Pawelek J. L-tyrosine stimulates induction of tyrosinase activity by MSH and reduces cooperative interactions between MSH receptors in hamster melanoma cells. Biosci Rep 1989: 9: 579-586.
21. Slominski A, Paus R. Towards defining receptors for L-tyrosine and L-dopa. Mol Cell Endocrinol 1994: 99: C7-C11.
22. Slominski A, Pruski D. L-dopa binding sites in rodent melanoma cells. Biochim Biophys Acta 1992: 1139: 324-328.
23. Costin G E, Hearing V J. Human skin pigmentation: Melanocytes modulate skin color in response to stress. FASEB J 2007: 21: 976-994.
24. Hearing V J. Biogenesis of pigment granules: A sensitive way to regulate melanocyte function. J Dermatol Sci 2005: 37: 3-14.
25. Slominski A, Wortsman J, Tuckey R C, Paus R. Differential expression of HPA axis homolog in the skin. Mol Cell Endocrinol 2007: 266: 143-149.
26. Slominski A, Wortsman J, Luger T, Paus R, Solomon S. Corticotropin releasing hormone and proopiomelanocortin involvement in the cutaneous response to stress. Physiol Rev 2000: 80: 979-1020.
27. Schallreuter K, Slominski A, Pawelek J M, Jimbow K, Gilchrest B A. What controls melanogenesis? Exp Dermatol 1998: 7: 143-150.
28. Slominski A, Wortsman J, Pisarchik A et al. Cutaneous expression of corticotropin releasing hormone (CRH), urocortin, and CRH receptors. FASEB J 2001: 15: 1678-1693.
29. Slominski A, Zbytek B, Zmijewski M et al. Corticotropin releasing hormone and the skin. Front Biosci 2006: 11: 2230-2248.
30. Slominski A, Ermak G, Hwang J, Chakraborty A, Mazurkiewicz J E, Mihm M. Proopiomelanocortin, corticotropin releasing hormone and corticotropin releasing hormone receptor genes are expressed in human skin. FEBS Lett 1995: 374: 113-116.
31. Slominski A, Zbytek B, Pisarchik A, Slominski R M, Wortsman J. CRH functions as a growth factor/cytokine in the skin. J Cell Physiol 2006: 206: 780-791.
32. Kauser S, Slominski A, Wei E T, Tobin D J. Modulation of the human hair follicle pigmentary unit by corticotropin-releasing hormone and urocortin peptides. FASEB J 2006: 20: 882-895.
33. Zbytek B, Pfeffer L M, Slominski A T. CRH inhibits NF-kappaB signaling in human melanocytes. Peptides 2006: 27: 3276-3283.
34. Pisarchik A, Slominski A T. Alternative splicing of CRH-R1 receptors in human and mouse skin: Identification of new variants and their differential expression. FASEB J 2001: 15: 2754-2756.
35. Slominski A. Identification of beta-endorphin, alpha-MSH and ACTH peptides in cultured human melanocytes, melanoma and squamous cell carcinoma cells by RP-HPLC. Exp Dermatol 1998: 7: 213-216.
36. Slominski A. POMC gene expression in hamster and mouse melanoma cells. FEBS Lett 1991: 291: 165-168.
37. Abdel-Malek Z, Scott M C, Suzuki I et al. The melanocortin-1 receptor is a key regulator of human cutaneous pigmentation. Pigment Cell Res 2000: 13 (Suppl. 8): 156-162.
38. Bohm M, Luger T A, Tobin D J, Garcia-Borron J C. Melanocortin receptor ligands: New horizons for skin biology and clinical dermatology. J Invest Dermatol 2006: 126: 1966-1975.
39. Slominski A, Ermak G, Mihm M. ACTH receptor, CYP11A1, CYP17 and CYP21A2 genes are expressed in skin. J Clin Endocrinol Metab 1996: 81: 2746-2749.
40. Spencer J D, Schallreuter K U. Regulation of pigmentation in human epidermal melanocytes by functional high affinity {beta}-MSH/MC4-R signalling. Endocrinology 2009: 150: 1250-1258.
41. Kauser S, Schallreuter K U, Thody A J, Gummer C, Tobin D J. Regulation of human epidermal melanocyte biology by beta-endorphin. J Invest Dermatol 2003: 120: 1073-1080.
42. Slominski A, Zjawiony J, Wortsman J et al. A novel pathway for sequential transformation of 7-dehydrocholesterol and expression of the P450scc system in mammalian skin. Eur J Biochem 2004: 271: 4178-4188.
43. Slominski A, Zbytek B, Szczesniewski A et al. CRH stimulation of corticosteroids production in melanocytes is mediated by ACTH. Am J Physiol Endocrinol Metab 2005: 288: E701-E706.
44. Slominski A, Gomez-Sanchez C E, Foecking M F, Wortsman J. Metabolism of progesterone to DOC, corticosterone and 18OHDOC in cultured human melanoma cells. FEBS Lett 1999: 455: 364-366.
45. Slominski A, Wortsman J, Mazurkiewicz J E et al. Detection of proopiomelanocortin-derived antigens in normal and pathologic human skin. J Lab Clin Med 1993: 122: 658-666.
46. Slominski A, Heasley D, Mazurkiewicz J E, Ermak G, Baker J, Carlson J A. Expression of proopiomelanocortin (POMC)-derived melanocyte-stimulating hormone (MSH) and adrenocorticotropic hormone (ACTH) peptides in skin of basal cell carcinoma patients. Hum Pathol 1999: 30: 208-215.
47. Zbytek B, Wortsman J, Slominski A. Characterization of a ultraviolet B-induced corticotropin-releasing hormone-proopiomelanocortin system in human melanocytes. Mol Endocrinol 2006: 20: 2539-2547.
48. Slominski A, Baker J, Ermak G, Chakraborty A, Pawelek J. Ultraviolet B stimulates production of corticotropin releasing factor (CRF) by human melanocytes. FEBS Lett 1996: 399: 175-176.
49. Rousseau K, Kauser S, Pritchard L E et al. Proopiomelanocortin (POMC), the ACTH/melanocortin precursor, is secreted by human epidermal keratinocytes and melanocytes and stimulates melanogenesis. FASEB J 2007: 21: 1844-1856.
50. Slominski A, Mihm M. Potential mechanism of skin response to stress. Int J Dermatol 1996: 35: 849-851.
51. Zmijewski M A, Sharma R K, Slominski A T. Expression of molecular equivalent of hypothalamic-pituitary-adrenal axis in adult retinal pigment epithelium. J Endocrinol 2007: 193: 157-169.
52. Slominski A. A nervous breakdown in the skin: Stress and the epidermal barrier. J Clin Invest 2007: 117: 3166-3169.
53. Slominski A, Wortsman J, Paus R, Tobin D, Elias P, Feingold K. Skin as an endocrine organ: Implications for its function. Drug Discov Today: Dis Mech 2008: 5: e137-e144.
54. Ito N, Ito T, Kromminga A et al. Human hair follicles display a functional equivalent of the hypothalamic-pituitary-adrenal axis and synthesize cortisol. FASEB J 2005: 19: 1332-1334.
55. Slominski A. Neuroendocrine system of the skin. Dermatology 2005: 211: 199-208.
56. Grando S A, Pittelkow M R, Schallreuter K U. Adrenergic and cholinergic control in the biology of epidermis: Physiological and clinical significance. J Invest Dermatol 2006: 126: 1948-1965.
57. Schallreuter K U, Kothari S, Chavan B, Spencer J D. Regulation of melanogenesis - controversies and new concepts. Exp Dermatol 2008: 17: 395-404.
58. Marles L K, Peters E M, Tobin D J, Hibberts N A, Schallreuter K U. Tyrosine hydroxylase isoenzyme I is present in human melanosomes: A possible novel function in pigmentation. Exp Dermatol 2003: 12: 61-70.
59. Schallreuter K U. A review of recent advances on the regulation of pigmentation in the human epidermis. Cell Mol Biol (Noisy-le-grand) 1999: 45: 943-949.
60. Slominski A, Semak I, Pisarchik A, Sweatman T, Szczesniewski A, Worstman J. Conversion of L-tryptophan to serotonin and melatonin in melanoma cells. FEBS Lett 2002: 511: 102-106.
61. Slominski A, Pisarchik A, Semak I et al. Serotoninergic and melatoninergic systems are fully expressed in human skin. FASEB J 2002: 16: 896-898.
62. Slominski A, Wortsman J, Tobin D J. The cutaneous serotoninergic/ melatoninergic system: Securing a place under the sun. FASEB J 2005: 19: 176-194.
63. Slominski A, Tobin D J, Zmijewski M A, Wortsman J, Paus R. Melatonin in the skin: Synthesis, metabolism and functions. Trends Endocrinol Metab 2008: 19: 17-24.
64. Slominski A, Pisarchik A, Johansson O et al. Tryptophan hydroxylase (TPH) expression in human skin cells. Biochim Biophys Acta 2003: 1639: 80-86.
65. Slominski A, Pisarchik A, Zbytek B, Tobin D J, Kauser S, Wortsman J. Functional activity of serotoninergic and melatoninergic systems expressed in the skin. J Cell Physiol 2003: 196: 144-153.
66. Slominski A, Fischer T W, Zmijewski M A et al. On the role of melatonin in skin physiology and pathology. Endocrine 2005: 27: 137-148.
67. Slominski A, Wortsman J, Kohn L et al. Expression of hypothalamic-pituitary-thyroid axis related genes in the human skin. J Invest Dermatol 2002: 119: 1449-1455.